Head and neck cancers, version 1.2015 featured updates to the NCCN guidelines
| Autor: | Pfister, DG, Spencer, S, Brizel, DM, Burtness, B, Busse, PM, Caudell, JJ, Cmelak, AJ, Colevas, AD, Dunphy, F, Eisele, DW, Foote, RL, Gilbert, J, Gillison, ML, Haddad, RI, Haughey, BH, Hicks, WL, Hitchcock, YJ, Jimeno, A, Kies, MS, Lydiatt, WM, Maghami, E, McCaffrey, T, Mell, LK, Mittal, BB, Pinto, HA, Ridge, JA, Rodriguez, CP, Samant, S, Shah, JP, Weber, RS, Wolf, GT, Worden, F, Yom, SS, McMillian, N, Hughes, M |
|---|---|
| Rok vydání: | 2015 |
| Předmět: | |
| Zdroj: | JNCCN Journal of the National Comprehensive Cancer Network, vol 13, iss 7 Pfister, DG; Spencer, S; Brizel, DM; Burtness, B; Busse, PM; Caudell, JJ; et al.(2015). Head and neck cancers, version 1.2015 featured updates to the NCCN guidelines. JNCCN Journal of the National Comprehensive Cancer Network, 13(7), 847-856. doi: 10.6004/jnccn.2015.0102. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/1zw4b66x |
| Popis: | © JNCCN-Journal of the National Comprehensive Cancer Network. These NCCN Guidelines Insights focus on recent updates to the 2015 NCCN Guidelines for Head and Neck (H&N) Cancers. These Insights describe the different types of particle therapy that may be used to treat H&N cancers, in contrast to traditional radiation therapy (RT) with photons (x-ray). Research is ongoing regarding the different types of particle therapy, including protons and carbonions, with the goals of reducing the long-term side effects from RT and improving the therapeutic index. For the 2015 update, the NCCN H&N Cancers Panel agreed to delete recommendations for neutron therapy for salivary gland cancers, because of its limited availability, which has decreased over the past 2 decades; the small number of patients in the United States who currently receive this treatment; and concerns that the toxicity of neutron therapy may offset potential disease control advantages. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|